Published in AIDS Weekly, December 19th, 2005
According to a study from England, "Increasing numbers of patients are choosing to interrupt highly active antiretroviral therapy (HAART). We describe the effect of patient-directed treatment interruption (PDTI) on plasma viral loads (pVL), proviral DNA (pDNA), lymphocyte subsets, and immune responses in 24 chronically HIV-1 infected individuals."
"Patients were divided into group A with pVL>50 copies/mL and group B with pVL <50 copies/mL, prior to the PDTI. pVL rose significantly in group B during the first month off HAART and was associated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.